Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 23;10(13):2757.
doi: 10.3390/jcm10132757.

Feasibility of Secondary Follicle Isolation, Culture and Achievement of In-Vitro Oocyte Maturation from Superovulated Ovaries: An Experimental Proof-of-Concept Study Using Mice

Affiliations

Feasibility of Secondary Follicle Isolation, Culture and Achievement of In-Vitro Oocyte Maturation from Superovulated Ovaries: An Experimental Proof-of-Concept Study Using Mice

Xia Hao et al. J Clin Med. .

Abstract

Fertility preservation through ovarian stimulation, aiming at cryopreserving mature oocytes or embryos, is sometimes unsuccessful. This clinical situation deserves novel approaches to overcome infertility following cancer treatment in patients facing highly gonadotoxic treatment. In this controlled experimental study, we investigated the feasibility of in-vitro culturing secondary follicles isolated from superovulated ovaries of mice recently treated with gonadotropins. The follicle yields of superovulated ovaries were 45.9% less than in unstimulated controls. Follicles from superovulated ovaries showed faster growth pace during the initial 7 days of culture and secreted more 17β-estradiol by the end of culture vs controls. Parameters reflecting the outcome of follicular development and oocyte maturation competence in vitro were similar between superovulated and control groups, with a similar follicle size at the end of culture and around 70% survival. Nearly half of cultured follicles met the criteria for in-vitro maturation in both groups and approximately 60% of those achieved a mature MII oocyte, similarly in both groups. Over 60% of obtained MII oocytes displayed normal-looking spindle and chromosome configurations, without significant differences between the groups. Using a validated follicle culture system, we demonstrated the feasibility of secondary follicle isolation, in-vitro culture and oocyte maturation with normal spindle and chromosome configurations obtained from superovulated mice ovaries.

Keywords: female fertility preservation; follicle isolation; in-vitro maturation; ovarian tissue; secondary follicle culture; superovulation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
(a) Follicular growth curves during in-vitro culture; (b) 17β-estradiol secreted by individual follicles in the culture medium; (c) Representative images showing a normal or abnormal morphology of spindle and chromosome configurations in MII oocytes from control and superovulated groups after IVM. Spindle fibers (green) were detected by immunofluorescence for a-tubulin, while DNA (red) was stained with propidium iodide. Scale bar, 10 µm; (d) Percentages of MII oocytes with spindle defects or chromosome misalignment in control and superovulated groups.

Similar articles

References

    1. World Health Organization. [(accessed on 21 January 2021)]; Available online: https://www.who.int/health-topics/cancer#tab=tab_1.
    1. Miller K.D., Nogueira L., Mariotto A.B., Rowland J.H., Yabroff K.R., Alfano C.M., Jemal A., Kramer J.L., Siegel R.L. Cancer treatment and survivorship statistics, 2019. CA Cancer J. Clin. 2019;69:363–385. doi: 10.3322/caac.21565. - DOI - PubMed
    1. Duffy C., Allen S. Medical and psychosocial aspects of fertility after cancer. Cancer J. 2009;15:27–33. doi: 10.1097/PPO.0b013e3181976602. - DOI - PMC - PubMed
    1. Abedelahi A., Rezaei-Tavirani M., Mohammadnejad D. Fertility preservation among the cancer patients by ovarian tissue cryopreservation, transplantation, and follicular development. Iran. J. Cancer Prev. 2013;6:123–132. - PMC - PubMed
    1. Rodriguez-Wallberg K.A., Oktay K. Fertility preservation during cancer treatment: Clinical guidelines. Cancer Manag. Res. 2014;6:105–117. - PMC - PubMed

LinkOut - more resources